Debut Plus

₹8,055.5

▼ -30.73 -0.38%

17 Jul 2026

NSE Listed · Healthcare

AstraZeneca Pharma Ind Ltd. (ASTRAZEN)

Volume: 737Avg Vol 1W: 3,138Avg Vol 1M: 2,84852W Range:₹7,551.5₹9,849.5
NSE BSE www.astrazeneca.in
Key Ratios
Checked 5h ago
Market Cap₹20,215 Cr
Current Price₹8,055.5
Previous Close₹8,086.23
High / Low (52w)₹9,849.5 / ₹7,551.5
Volume737
Avg Vol (1W)3,138
Avg Vol (1M)2,848
Stock P/E450.47
Book Value₹349.12
Dividend Yield44%
ROE21.49%
ROA9.43%
Revenue (TTM)₹2,276 Cr
Revenue Growth—
Profit Margin8.24%
Total Debt—
Shares Outstanding3 Cr
Face Value₹2
EPS (TTM)₹76.57
P/B23.16
Debt / Equity0.03
50 DMA₹8,298.19
200 DMA₹8,431.79
Day change-0.38%
Price Chart
₹8,055.5▼ 11.04% · 1Y
₹9253₹775980K
2025-11-24
2026-07-16

20-day avg volume: 3K shares

Pros
  • Healthy return on equity of 21.5%.
  • Pays a dividend yield of 44.0%.
  • Company is almost debt-free.
  • Revenue grew 32% YoY.
Cons
  • Stock trades at a high P/E of 450.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹388 Cr₹408 Cr₹440 Cr₹480 Cr₹526 Cr₹559 Cr₹612 Cr₹579 Cr
EBITDA₹43 Cr₹51 Cr₹76 Cr₹85 Cr₹76 Cr₹79 Cr₹46 Cr₹61 Cr
Net Profit₹-12 Cr₹38 Cr₹31 Cr₹58 Cr₹56 Cr₹54 Cr₹33 Cr₹45 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹583 Cr₹745 Cr₹845 Cr₹826 Cr₹820 Cr₹1,029 Cr₹1,330 Cr₹1,757 Cr
EBITDA₹44 Cr₹73 Cr₹115 Cr₹128 Cr₹84 Cr₹175 Cr₹204 Cr₹255 Cr
Net Profit₹26 Cr₹54 Cr₹72 Cr₹93 Cr₹62 Cr₹99 Cr₹162 Cr₹116 Cr
EPS10.421.828.937.324.639.764.646.3
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹562 Cr₹706 Cr₹775 Cr₹857 Cr₹985 Cr₹1,078 Cr₹1,518 Cr₹1,989 Cr
Total Liabilities₹261 Cr₹342 Cr₹319 Cr₹345 Cr₹396 Cr₹366 Cr₹748 Cr₹1,116 Cr
Equity₹301 Cr₹364 Cr₹456 Cr₹511 Cr₹589 Cr₹712 Cr₹770 Cr₹873 Cr
Total Debt———————₹111 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹137 Cr₹126 Cr₹99 Cr₹84 Cr₹130 Cr₹-15 Cr
Investing₹173 Cr₹5 Cr₹18 Cr₹22 Cr₹31 Cr₹19 Cr
Financing₹-9 Cr₹-9 Cr₹-24 Cr₹-44 Cr₹-66 Cr₹-92 Cr
Free Cash Flow₹137 Cr₹126 Cr₹99 Cr₹84 Cr₹130 Cr₹-19 Cr
Shareholding
Promoter 75% Institutions 8.58% Public 16.42%
About AstraZeneca Pharma Ind Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company has a strategic collaboration with Leica Biosystems and Daiichi Sankyo Company, Limited for the development of an immunohistochemistry assay and an image analysis algorithm for the TROP2 NMR biomarker in non-small cell lung cancer. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

www.astrazeneca.in ↗
Efficiency & Working Capital
ROCE25.5%
Interest Coverage174.2
Dividend Payout—
Debtor Days39 d
Inventory Days117 d
Payable Days97 d
Cash Conversion Cycle59 d
Working Capital Days156 d
Shareholding Details

As of 2026-03-31

Promoter75%
FII2.8%
DII5.8%
Institutions8.6%
Public16.4%
Promoter Pledge0%
No. of Shareholders29,007
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters75%75%75%75%75%75%75%75%75%75%75%75%
FIIs2.7%2.7%2.7%2.7%2.8%2.9%2.9%2.9%3%2.7%2.7%2.8%
DIIs1.9%2.4%2.8%3.8%5%5.1%5.2%4.7%4.6%5.3%5.6%5.8%
Public20.4%19.9%19.6%18.5%17.2%17%16.9%17.5%17.4%17%16.7%16.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders38,94632,38029,03229,41827,16927,61527,32232,46634,37832,91431,55129,007
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Astrazeneca Pharmaceuticals AbShareholding of Promoter and Promoter Group75%1.88 Cr
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund(various Schemes)Public Shareholding2.9%7,22,952
Tejas Bhalchandra TrivediPublic Shareholding2.7%6,69,078
Shivani Tejas TrivediPublic Shareholding2.4%6,00,299
Bandhan - Various SchemesPublic Shareholding1.1%2,81,692
Icici Prudential - Various SchemesPublic Shareholding1.1%2,79,994
Prashant JainPublic Shareholding1.1%2,76,000
Astrazeneca AbShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Astrazeneca Pharmaceuticals Ab00%2026-03-31
Astrazeneca Ab00%2026-03-31
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund(various Schemes)00%2026-03-31
Icici Prudential - Various Schemes00%2026-03-31
Bandhan - Various Schemes00%2026-03-31
Prashant Jain00%2026-03-31
Tejas Bhalchandra Trivedi00%2026-03-31
Shivani Tejas Trivedi00%2026-03-31
Astrazeneca Pharmaceuticals Ab00%2025-12-31
Astrazeneca Ab00%2025-12-31
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund(various Schemes)00%2025-12-31
Prashant Jain00%2025-12-31
Board of Directors
NameDesignationYear
Revathy AshokIndependent Director2025
Shilpa Divekar NirulaChairperson2025
Hooi Bien ChuahNon Executive Director2025
Sylvia Lorena Varela RamonNon Executive Director2025
Bhavana AgrawalExecutive Director2025
MONICA WIDHANIIndependent Director2025
Jesus Javier Diaz-Ropero EstesoNon Executive Director2025
Praveen Rao AkkinepallyManaging Director2025
Segments — Product
SegmentRevenueShare
Healthcare₹518 Cr96%
Others₹22 Cr4%
Segments — Geography
RegionRevenueShare
India₹1,607 Cr93.6%
Outside India₹110 Cr6.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹2555
Corporate Actions
TypeDateValueRemark
dividend2025-07-18₹32 (1600%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202570091,2661,328
202570091,1621,223
20250000105105
Company Information
Incorporated1979
ChairmanShilpa Divekar Nirula
AuditorPrice Waterhouse & Co Chartered Accountants LLP
Investor Email[email protected]
🌐 www.astrazeneca.in ↗

📍 Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road, Bangalore, Karnataka, 560045

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Aspire & Innovative Adv LimitedAsian Star Co.Ltd.Astec Lifesciences Ltd.Aster DM Healthcare Ltd.Astral LimitedAstra Microwave Ltd.Astron Paper & Board MillAtal Realtech LimitedAtam Valves LimitedATC Energies System Ltd.Adani Total Gas LimitedAther Energy LimitedAll “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search